Source: Annual Congress 2002 - Thoracic oncology: biology
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
J. G. Edwards, D. Swinson, L. Jones, D. A. Waller, K. J. O'Byrne (Leicester, United Kingdom). Tumour necrosis correlates with angiogenesis and is a prognostic factor in malignant mesothelioma. Eur Respir J 2002; 20: Suppl. 38, 1513

Member's Comments

No comment yet.

Related content which might interest you: Spread and histology of malignant tracheal tumor – as independent prognostic factors Source: Eur Respir J 2005; 26: Suppl. 49, 174s Year: 2005 Apoptosis, tumor cell proliferation and angiogenesis as prognostic factor in lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 78s Year: 2004 Evaluation levels of pro-inflammatory cytokines tumour necrosis factor (TNF)-alpha and interferon (IFN)-gamma in lung cancer complicated with metastatic pleurisy Source: Eur Respir J 2001; 18: Suppl. 33, 233s Year: 2001 Is comorbidity a good prognostic factor for malignant pleural mesothelioma? Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology Year: 2008 Tumor-related angiogenesis: role in tumour growth and metastasis formation Source: Annual Congress 2005 - Update on the role of angiogenesis in the pathogenesis and treatment of lung diseases Year: 2005 Vascular endothelial growth factor (VEGF) in malignant and tuberculous pleural effusions Source: Eur Respir J 2001; 18: Suppl. 33, 397s Year: 2001 Vascular endothelial growth factor and tumor necrosis factor gene polymorphisms in Turkish patients with sarcoidosis Source: Eur Respir J 2006; 28: Suppl. 50, 353s Year: 2006 Alteration of neutrophil invasion toward malignant mesothelioma by Interleukin-10 Source: Eur Respir J 2002; 20: Suppl. 38, 231s Year: 2002 Expression of tumor necrosis factor receptor 2 in human non-small cell lung cancer and its role as a potential prognostic biomarker Source: International Congress 2019 – Biology of lung cancer Year: 2019 PP133 – IGF1R acts in the tumor microenvironment as a cancer-promoting factor facilitating the implantation and progression of lung metastasis Source: ERS Lung Science Conference 2021 Year: 2021 Prognostic role of epidermal growth factor receptor in stage III nonsmall cell lung cancer Source: Eur Respir J 2005; 25: 329-335 Year: 2005 Tumour marker in pulmonary carcinoid Source: Annual Congress 2008 - Various thoracic tumours and interesting cases Year: 2008 Frequent epidermal growth factor receptor gene mutations in malignant pleural effusion of lung adenocarcinoma Source: Eur Respir J 2008; 32: 924-930 Year: 2008 The prognostic factor of lung abscess Source: Annual Congress 2010 - Bronchiectasis and respiratory infections caused by Pseudomonas Year: 2010 Pre-therapeutic staging and prognostic factors in malignant pleural mesothelioma patients Source: Annual Congress 2009 - Malignant pleural mesothelioma guidelines Year: 2009 All-trans-retinoic acid inhibits tumour growth of malignant pleural mesothelioma in mice Source: Eur Respir J 2009; 34: 1159-1167 Year: 2009 Tumour necrosis factor and lymphotoxin A polymorphisms: a relationship with COPD and its progression? Source: Eur Respir J 2007; 29: 8-10 Year: 2007 Risk of chemotherapy-induced pulmonary fibrosis is associated with polymorphic tumour necrosis factor-a2 gene Source: Eur Respir J 2002; 19: 912-918 Year: 2002 Vascular endothelial growth factor C is a predictor of early recurrence and poor prognosis of resected stage I non-small cell lung cancer in Taiwan Source: Annual Congress 2010 - Prognostic factors for lung cancer Year: 2010 Prognostic value of non-angiogenic and angiogenic growth patterns in non-small cell lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 40s Year: 2004